CYLD and skin cancer: In addition to BCCs, which arises in mice expressing GLI1 in the skin, these mice also develop cylindroma and trichoepitheliomas [43], suggesting that the loss or inactivation of CYLD in different skin cancer diseases can affect the same signaling pathway.